| Product NDC: | 51672-2016 |
| Proprietary Name: | Triple Antibiotic |
| Non Proprietary Name: | Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
| Active Ingredient(s): | 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g & nbsp; Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-2016 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 19951214 |
| Package NDC: | 51672-2016-1 |
| Package Description: | 1 TUBE in 1 CARTON (51672-2016-1) > 14.2 g in 1 TUBE |
| NDC Code | 51672-2016-1 |
| Proprietary Name | Triple Antibiotic |
| Package Description | 1 TUBE in 1 CARTON (51672-2016-1) > 14.2 g in 1 TUBE |
| Product NDC | 51672-2016 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 19951214 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 3.5; 5000 |
| Strength Unit | [iU]/g; mg/g; [iU]/g |
| Pharmaceutical Classes |